CORONARY ANGIOPLASTY

This adverse event was reported 453 times

These drugs are most commonly taken by patients reporting CORONARY ANGIOPLASTY:

# Drug Count
0 ASPIRIN 83
1 CLOPIDOGREL 81
2 ASPIRIN 325 MG 77
3 ASPIRIN 81 MG 77
4 ATORVASTATIN CALCIUM 37
5 SIMVASTATIN 36
6 CLOPIDOGREL BISULFATE 34
7 METOPROLOL TARTRATE 34
8 METOPROLOL 29
9 FUROSEMIDE 28
See all common drugs associated with CORONARY ANGIOPLASTY

CORONARY ANGIOPLASTY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM-JMDB 2 0.0044
1 ERGOTAMINE TARTRATE AND CAFFEINE 1 0.0037
2 MINERAL OIL, WHITE PETROLATUM 1 0.0035
3 FOSFOMYCIN TROMETHAMINE 2 0.0033
4 MEXILETINE HYDROCHLORIDE 1 0.0024
5 SACCHAROMYCES CEREVISIAE 2 0.0022
6 CEFOXITIN SODIUM 2 0.0014
7 POTASSIUM ACETATE 2 0.0014
8 VERICIGUAT 1 0.0010
9 NISOLDIPINE 1 0.0008
See all drugs enriched for association with CORONARY ANGIOPLASTY

CORONARY ANGIOPLASTY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Non-Standardized Fungal Allergenic Extract [EPC] 2 0.0009
2 Anti-anginal [EPC] 6 0.0006
3 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
4 Glinide [EPC] 4 0.0004
5 Quinolone Antimicrobial [EPC] 3 0.0003
6 Nitrate Vasodilator [EPC] 26 0.0003
7 PCSK9 Inhibitor [EPC] 7 0.0003
8 P2Y12 Platelet Inhibitor [EPC] 26 0.0002
9 Antifibrinolytic Agent [EPC] 2 0.0002
See all drug classes enriched for association with CORONARY ANGIOPLASTY